The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges
Essays in Biochemistry · 08.09.2025 · 69 (02) · 63-75
DOI: 10.1042/ebc20253006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Essays in Biochemistry, online erschienen am 07.03.2025. Verfasst von Beilei Yue und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedicine and Health and College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Neoplasms, Membrane Proteins, Signal Transduction. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The cyclic GMP-AMP synthase–stimulator of interferon genes (cGAS-STING) pathway is a crucial component of the host’s innate immunity and plays a central role in detecting cytosolic double-stranded DNA from endogenous and exogenous sources. Upon activation, cGAS synthesizes cGAMP, which binds to STING, triggering a cascade of immune responses, including the production of type I interferons and pro-inflammatory cytokines. In the context of cancers, the cGAS-STING pathway can exert dual roles: on the one hand, it promotes anti-tumor immunity by enhancing antigen presentation, stimulating T-cell responses, and inducing direct tumor cell apoptosis. On the other hand, chronic activation, particularly in tumors with chromosomal instability, can lead to immune suppression and tumor progression. Persistent cGAS-STING signaling results in the up-regulation of immune checkpoint molecules such as PD-L1, contributing to immune evasion and metastasis. Consequently, anti-tumor strategies targeting the cGAS-STING pathway have to consider the balance of immune activation and the immune tolerance caused by chronic activation. This review explores the mechanisms underlying both the anti-tumor and protumor roles of the cGAS-STING pathway, with a focus on potential therapeutic approaches, and the challenges faced in their clinical application, along with corresponding solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biomedicine and Health and College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
- Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, NY 14260, U.S.A.
- Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
- Hubei Province Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, China.
ORCID-Profile: Beilei Yue, Honglin Jin, Jing Huang
Zitieren
APA
Yue, B., Gao, W., Lovell, J. F., Jin, H., & Huang, J. (2025). The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges. Essays in Biochemistry, 69(02), 63-75. https://doi.org/10.1042/ebc20253006
Vancouver
Yue B, Gao W, Lovell JF, Jin H, Huang J. The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges. Essays in Biochemistry. 2025;69(02):63-75. doi:10.1042/ebc20253006
BibTeX
@article{Yue2025,
author = {Yue, Beilei and Gao, Wenbo and Lovell, Jonathan F and Jin, Honglin and Huang, Jing},
title = {The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges},
journal = {Essays in Biochemistry},
year = {2025},
volume = {69},
number = {02},
pages = {63--75},
doi = {10.1042/ebc20253006}
}
EUVIMED